Indian Immunologicals says 'over-cautionary and misplaced reference' to 2023 made in Australian advisory, it 'does not reflect the current situation'.
Australian health authorities have raised concerns over alleged counterfeit versions of the rabies vaccine Abhayrab in India, prompting a response from its manufacturer, Indian Immunologicals (IIL). The company clarified that the issue pertained to a... [1524 chars]